No clinically important response to treatment ‐ short term · patients with schizophrenia
It is very uncertain whether ADJUNCTIVE BENZODIAZEPINES + ANTIPSYCHOTICS changes no clinically important response to treatment ‐ short term (3 weeks… compared with PLACEBO/NO ADJUNCTIVE TREATMENT + ANTIPSYCHOTICS (very low certainty).
1 finding from 1 review
Mortality: in‐hospital mortality (within 24 hours) · all conditions
Transfusion of RBCs of shorter showed no clear difference in mortality: in‐hospital mortality (within 24 hours) compared with longer storage duration (low certainty).
1 finding from 1 review
Mortality: in‐hospital mortality (within 7 days) · all conditions
It is very uncertain whether transfusion of RBCs of shorter changes mortality: in‐hospital mortality (within 7 days) compared with longer storage duration (very low certainty).
1 finding from 1 review
Mortality: time‐point not defined · all conditions
It is very uncertain whether transfusion of RBCs of shorter changes mortality: time‐point not defined compared with longer storage duration (very low certainty).
1 finding from 1 review
Mortality: short term (up to 30 days) · all conditions
Transfusion of RBCs of shorter showed no clear difference in mortality: short term (up to 30 days) compared with longer storage duration (low certainty).
1 finding from 1 review
Quality of sleep · Shift workers
1 finding from 1 review
no estimate extracted
111 participants
Very low
Sleep length off‐shift · Shift workers
1 finding from 1 review
no estimate extracted
121 participants
Very low
Sleepiness during shifts · Shift workers
1 finding from 1 review
no estimate extracted
121 participants
Very low
Overtime · Shift workers
1 finding from 1 review
no estimate extracted
59 participants
Very low
Other secondary outcomes (number of staff; number of hours worked; staff costs) · Shift workers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life · People aged 12 years and over with painful TMD lasting 3 months or longer
The review found no eligible studies for this question.
1 finding from 1 review
Reduction in pain intensity · People aged 12 years and over with painful TMD lasting 3 months or longer
Cognitive behavioural therapy (CBT) showed no clear difference in pain intensity at treatment completion compared with alternative (active) treatment (e.g. oral splint, medication,… (low certainty).
2 findings from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · People aged 12 years and over with painful TMD lasting 3 months or longer
Relaxation showed no clear difference in pain intensity compared with occlusal (oral) appliance; GRADE not reported.
1 finding from 1 review
Psychological therapies for temporomandibular disorders (TMDs) 2022 · Cochrane All outcomesTreatment completion · Adolescents (12-19 years)
Not pooled. Wahlund 2015: MD 3.70 (95% CI -1.21 to 8.61), n=57 (relaxation 28, appliance 29); Wahlund 2003: MD not reported, n=83 (relaxation 41, appliance 42). Both studies were in adolescents; the occlusal appliance…
2 studies · 140 participants
GRADE not reported
Mental distress · People aged 12 years and over with painful TMD lasting 3 months or longer
Cognitive behavioural therapy (CBT) may leads to lower psychological distress at follow-up compared with alternative (active) treatment (e.g. oral splint, medication,… (low certainty).
2 findings from 1 review
Adverse events · People aged 12 years and over with painful TMD lasting 3 months or longer
1 finding from 1 review
Only 1 study reported adverse events as an outcome (Litt 2010): it found worsening symptoms in 13 people treated with an oral splint (as part of standard treatment) and 4 people treated with CBT.
1 study · 101 participants
Very low
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · People aged 12 years and over with painful TMD lasting 3 months or longer
Hope-based intervention showed no clear difference in pain intensity compared with pain education; GRADE not reported.
1 finding from 1 review
Adverse events · People aged 12 years and over with painful TMD lasting 3 months or longer
1 finding from 1 review
Additional physical symptoms · People aged 12 years and over with painful TMD lasting 3 months or longer
The review found no eligible studies for this question.
1 finding from 1 review
Quality of life · People aged 12 years and over with painful TMD lasting 3 months or longer
The review found no eligible studies for this question.
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · People aged 12 years and over with painful TMD lasting 3 months or longer
1 finding from 1 review